Shares of Hinge Health Inc. (NYSE:HNGE - Get Free Report) have been given an average recommendation of "Buy" by the sixteen analysts that are presently covering the company, MarketBeat Ratings reports. Fifteen investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $49.8571.
A number of brokerages have issued reports on HNGE. KeyCorp lifted their price objective on Hinge Health from $45.00 to $60.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. Royal Bank Of Canada began coverage on Hinge Health in a research note on Monday, June 16th. They set an "outperform" rating and a $45.00 price objective for the company. Wall Street Zen upgraded Hinge Health to a "hold" rating in a research note on Monday, June 2nd. JMP Securities began coverage on Hinge Health in a report on Monday, July 14th. They issued a "market outperform" rating and a $58.00 target price for the company. Finally, Morgan Stanley began coverage on Hinge Health in a report on Monday, June 16th. They issued an "overweight" rating and a $46.00 target price for the company.
Read Our Latest Analysis on HNGE
Institutional Trading of Hinge Health
Several large investors have recently modified their holdings of HNGE. Emerald Advisers LLC bought a new stake in shares of Hinge Health in the second quarter worth $108,000. FNY Investment Advisers LLC bought a new stake in shares of Hinge Health in the second quarter worth $310,000. Strategic Blueprint LLC bought a new stake in shares of Hinge Health in the second quarter worth $346,000. Finally, CHURCHILL MANAGEMENT Corp bought a new stake in shares of Hinge Health in the second quarter worth $828,000.
Hinge Health Price Performance
Shares of NYSE:HNGE opened at $48.27 on Tuesday. The company's fifty day moving average is $43.30. Hinge Health has a 12-month low of $33.42 and a 12-month high of $52.16.
Hinge Health Company Profile
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
